Dose-specific effects of denosumab on serum calcium levels in patients with osteoporosis and various renal functions
Patients with osteoporosis and advanced chronic kidney disease (CKD) are at increased risk for hypocalcemia when initiating denosumab. It remains unclear if subsequent doses of denosumab pose similar hypocalcemia risk as the initial dose does. To study dose-specific hypocalcemia risks of denosumab....
Gespeichert in:
Veröffentlicht in: | The journal of clinical endocrinology and metabolism 2024-10 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!